May 9 |
AEON Biopharma Provides Update on Development Pipeline
|
May 3 |
US Equity Markets Close Higher Friday Following Weak Jobs Report
|
May 3 |
Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why
|
May 3 |
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
|
Apr 19 |
Here's Why AEON Biopharma, Inc. (AEON) Is a Great 'Buy the Bottom' Stock Now
|
Mar 31 |
CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants
|
Mar 29 |
AEON Biopharma Announces Redemption of Public Warrants
|
Mar 29 |
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
|